Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price rose 2.3% on Friday . The stock traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 shares were traded during mid-day trading, an increase of 138% from the average daily volume of 94,405 shares. The stock had previously closed at €45.52 ($46.93).
Carl Zeiss Meditec Price Performance
The firm has a market cap of $4.12 billion, a price-to-earnings ratio of 20.18, a P/E/G ratio of 2.83 and a beta of 0.98. The company has a current ratio of 3.51, a quick ratio of 2.47 and a debt-to-equity ratio of 6.74. The stock’s fifty day moving average price is €54.62 and its 200-day moving average price is €60.46.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- The 3 Best Blue-Chip Stocks to Buy Now
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
